申请人:Angell Martyn Richard
公开号:US20050065195A1
公开(公告)日:2005-03-24
Compounds of formula (I), wherein R3 is the group; or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
式(I)的化合物,其中R3为该基团;或其药学上可接受的盐或溶剂合物,并且它们可用作药物,特别是作为p38激酶抑制剂。